
Is hVIVO PLC Redefining Clinical Trial Services with a Strategic Acquisition?
Is hVIVO PLC Redefining Clinical Trial Services with a Strategic Acquisition?
- February 28, 2025 05:32 AM GMT
- Team Kalkine Media

Could B&M's Profit Warning Reflect a Broader Retail Challenge?
Could B&M's Profit Warning Reflect a Broader Retail Challenge?
- February 28, 2025 05:32 AM GMT
- Team Kalkine Media

Could US Tariffs Reshape Transatlantic Trade Dynamics?
Could US Tariffs Reshape Transatlantic Trade Dynamics?
- February 28, 2025 05:31 AM GMT
- Team Kalkine Media

State Street to Acquire Mizuho Financial Group’s Global Custody Business
TOKYO, February 28, 2025--(BUSINESS WIRE)--State Street Corporation (NYSE: STT) and Mizuho Financial Group, Inc. (President & Group CEO: Masahiro Kihara) today announced they have entered into an agre...
- February 28, 2025 05:30 AM GMT
- EODHD

Will BP PLC Redefine Its Energy Strategy Amid Global Shifts?
Will BP PLC Redefine Its Energy Strategy Amid Global Shifts?
- February 28, 2025 05:30 AM GMT
- Team Kalkine Media

Will Geopolitical Decisions Reshape the Cobalt Supply Chain?
Will Geopolitical Decisions Reshape the Cobalt Supply Chain?
- February 28, 2025 05:30 AM GMT
- Team Kalkine Media

Can Haleon PLC Drive Growth in the Consumer Health Sector?
Can Haleon PLC Drive Growth in the Consumer Health Sector?
- February 28, 2025 05:30 AM GMT
- Team Kalkine Media

Supramolecular polymers: the future of biomedical and engineering solutions
Molecular structures of NAGA derivative H-bond units and the applications of PNAGA-derived supramolecular polymer materials. GA, UNITED STATES, February 28, 2025 /EINPresswire.com/ -- A new study has...
- February 28, 2025 05:23 AM GMT
- EIN Presswire

Agilent to Participate in TD Cowen Health Care Conference
SANTA CLARA, Calif., February 28, 2025--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will participate in a fireside ch...
- February 28, 2025 02:29 AM GMT
- EODHD

Amerigo Scientific Releases Transglutaminase Inhibitors to Unlock Their Therapeutic Potential in Diseases
Amerigo Scientific announces its transglutaminase inhibitors, designed to advance research into their therapeutic applications across a range of diseases. NEW YORK, NY, UNITED STATES, February 27, 202...
- February 28, 2025 02:13 AM GMT
- EIN Presswire